{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:27:56Z","timestamp":1778232476918,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020424","name":"Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ygyno.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T22:25:10Z","timestamp":1710800710000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic"],"prefix":"10.1016","volume":"183","author":[{"given":"Muhammad Danyal","family":"Ahsan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel A.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rylee","family":"McGonigle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse T.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle R.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Enriquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Cantillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Holcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloise","family":"Chapman-Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie V.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi N.","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa K.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.03.004_bb0005","series-title":"SEER Cancer Stat Facts: Female Breast Cancer","author":"The Surveillance E, and End Results Program","year":"2023"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0010","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S1470-2045(19)30275-X","article-title":"MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial","volume":"20","author":"Saadatmand","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(20)30398-3","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality (UK age trial): final results of a randomised, controlled trial","volume":"21","author":"Duffy","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0025","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","article-title":"Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)","volume":"365","author":"Leach","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0035","series-title":"Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Breast Cancer Screening and Diagnosis V.3","author":"NCCN","year":"2023"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0040","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S1470-2045(23)00590-9","article-title":"Breast cancer screening: one size does not fit all","volume":"24","author":"The Lancet","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41523-017-0035-5","article-title":"The WISDOM study: breaking the deadlock in the breast cancer screening debate","volume":"3","author":"Esserman","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr1750","article-title":"Breast cancer risk-assessment models","volume":"9","author":"Evans","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0055","first-page":"698","article-title":"Medications to decrease the risk for breast cancer in women: recommendations from the U.S. preventive services task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/1055-9965.EPI-12-0570","article-title":"Which risk model to use? Clinical implications of the ACS MRI screening guidelines","volume":"22","author":"Ozanne","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41416-019-0476-8","article-title":"A systematic review and quality assessment of individualised breast cancer risk prediction models","volume":"121","author":"Louro","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0075","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.31961","article-title":"Risk factors for endometrial cancer: an umbrella review of the literature","volume":"145","author":"Raglan","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"Lukasiewicz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12885-018-4313-x","article-title":"Gynecologic cancer survivor preferences for long-term surveillance","volume":"18","author":"Schlumbrecht","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2023.04.001","article-title":"Web-based tool for cancer family history collection: a prospective randomized controlled trial","volume":"173","author":"Frey","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0095","first-page":"232","article-title":"Genetic analysis of breast cancer in the cancer and steroid hormone study","volume":"48","author":"Claus","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0105","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2019.11885","article-title":"Medication use to reduce risk of breast cancer: US preventive services task Force recommendation statement","volume":"322","author":"Force","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10689-013-9641-z","article-title":"Self administered screening for hereditary cancers in conjunction with mammography and ultrasound","volume":"12","author":"McDonnell","year":"2013","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0125","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1002\/cncr.33767","article-title":"Performance of the IBIS\/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women\u2019s Health Initiative","volume":"127","author":"Kurian","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0130","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and bowel project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djk050","article-title":"Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial","volume":"99","author":"Powles","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0140","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0145","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","article-title":"Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis","volume":"28","author":"Ropka","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cdp.2007.08.003","article-title":"Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers","volume":"31","author":"Sabatino","year":"2007","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.ygyno.2024.03.004_bb0160","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/jwh.2014.4742","article-title":"Use of the Gail model and breast cancer preventive therapy among three primary care specialties","volume":"23","author":"Corbelli","year":"2014","journal-title":"J. Women\u2019s Health (Larchmt)"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0165","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jama.2019.5780","article-title":"Medication use for the risk reduction of primary breast cancer in women: updated evidence report and systematic review for the US preventive services task Force","volume":"322","author":"Nelson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092535","article-title":"Tempfer C: tamoxifen and endometrial cancer: a Janus-headed drug","volume":"12","author":"Emons","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2024.03.004_bb0175","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824001434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:07:22Z","timestamp":1717499242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824001434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"alternative-id":["S0090825824001434"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}